Back to Search Start Over

Does sharp drop in HT use explain declining breast cancer rates?

Source :
Contemporary OB/GYN; Nov2007, Vol. 52 Issue 11, p30-30, 1/2p
Publication Year :
2007

Abstract

The article discusses the possible link of the drop in hormone therapy (HT) use to declining breast cancer rates. Anderson Cancer Center researcher Peter Ravdin explained at the 2007 North American Medical Society conference that clinical trial evidence show that combined estrogen/progestin use pose a particular risk for breast cancer. Their study showed that while a 50% drop in HT use due to reports linking HT use to a higher breast cancer risk could be the cause for changes in breast cancer rates, other causes can not be excluded.

Details

Language :
English
ISSN :
00903159
Volume :
52
Issue :
11
Database :
Complementary Index
Journal :
Contemporary OB/GYN
Publication Type :
Academic Journal
Accession number :
27523219